NCT03250507View on ClinicalTrials.gov

Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

January 30, 2019

Study Completion Date

January 30, 2019

Conditions
Hysterectomy
Interventions
DRUG

Bupivacaine

0.25% bupivacaine for TAP block

DRUG

Liposomal bupivacaine

Exparel for TAP block

DRUG

Saline

Saline for TAP block that will be mixed with liposomal bupivacaine to bring the liposomal bupivacaine group to 60 mL total volume.

Trial Locations (1)

48202

Henry Ford Hospital, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT03250507 - Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy | Biotech Hunter | Biotech Hunter